A Chromatin-bound Kinase, ERK8, Protects Genomic Integrity by Inhibiting HDM2-mediated Degradation of the DNA Clamp PCNA

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 2010 Aug 25

PMID 20733054

Citations 37

Authors

Angela L Groehler

Deborah A Lannigan

Affiliations

Soon will be listed here.

Abstract

Proliferating cell nuclear antigen (PCNA) acts as a scaffold, coordinator, and stimulator of numerous processes required for faithful transmission of genetic information. Maintaining PCNA levels above a critical threshold is essential, but little is known about PCNA protein turnover. We now show that ERK8 (extracellular signal-regulated kinase 8) is required for PCNA protein stability. ERK8 contains a conserved PCNA-interacting protein (PIP) box. Chromatin-bound ERK8 (ERK8(CHROMATIN)) interacts via this motif with PCNA(CHROMATIN), which acts as a platform for numerous proteins involved in DNA metabolism. Silencing ERK8 decreases PCNA levels and increases DNA damage. Ectopic expression of PCNA blocks DNA damage induced by ERK8 loss. ERK8 prevents HDM2-mediated PCNA destruction by inhibiting the association of PCNA with HDM2. This regulation is physiologically relevant as ERK8 activity is inhibited in transformed mammary cells. Our results reveal an unanticipated mechanism to control PCNA levels in normal cycling mammary epithelial cells and implicate ERK8 in the regulation of genomic stability.

Citing Articles

A Comprehensive Review of Protein Biomarkers for Invasive Lung Cancer.

Mezentsev A, Durymanov M, Makarov V Curr Oncol. 2024; 31(9):4818-4854.

PMID: 39329988 PMC: 11431409. DOI: 10.3390/curroncol31090360.

Mitogen-Activated Protein Kinase 15 Is a New Predictive Biomarker and Potential Therapeutic Target for Ovarian Cancer.

Zhong Q, Lau A, Xu Y Int J Mol Sci. 2024; 25(1).

PMID: 38203280 PMC: 10778700. DOI: 10.3390/ijms25010109.

Atypical MAP kinases - new insights and directions from amoeba.

Hadwiger J, Aranda R, Fatima S J Cell Sci. 2023; 136(20).

PMID: 37850857 PMC: 10617611. DOI: 10.1242/jcs.261447.

A FRET-Based Assay for the Identification of PCNA Inhibitors.

Hardebeck S, Schreiber S, Adick A, Langer K, Jose J Int J Mol Sci. 2023; 24(14).

PMID: 37511614 PMC: 10380293. DOI: 10.3390/ijms241411858.

Transcriptional upregulation of MAPK15 by NF-κB signaling boosts the efficacy of combination therapy with cisplatin and TNF-α.

Wu D, Dai L, Tan H, Zhao X, Wei Q, Zhong Q iScience. 2022; 25(12):105459.

PMID: 36425765 PMC: 9678736. DOI: 10.1016/j.isci.2022.105459.

References

Waga S, Stillman B . The DNA replication fork in eukaryotic cells. Annu Rev Biochem. 1998; 67:721-51. DOI: 10.1146/annurev.biochem.67.1.721. View

Xia L, Zheng L, Lee H, Bates S, Federico L, Shen B . Human 3-methyladenine-DNA glycosylase: effect of sequence context on excision, association with PCNA, and stimulation by AP endonuclease. J Mol Biol. 2005; 346(5):1259-74. DOI: 10.1016/j.jmb.2005.01.014. View

Mortusewicz O, Leonhardt H . XRCC1 and PCNA are loading platforms with distinct kinetic properties and different capacities to respond to multiple DNA lesions. BMC Mol Biol. 2007; 8:81. PMC: 2039748. DOI: 10.1186/1471-2199-8-81. View

Henderson D, Banga S, Grigliatti T, Boyd J . Mutagen sensitivity and suppression of position-effect variegation result from mutations in mus209, the Drosophila gene encoding PCNA. EMBO J. 1994; 13(6):1450-9. PMC: 394963. DOI: 10.1002/j.1460-2075.1994.tb06399.x. View

Vassilev L, Vu B, Graves B, Carvajal D, Podlaski F, Filipovic Z . In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004; 303(5659):844-8. DOI: 10.1126/science.1092472. View

Tanoue T, Adachi M, Moriguchi T, Nishida E . A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol. 2000; 2(2):110-6. DOI: 10.1038/35000065. View

Banks D, Wu M, Higa L, Gavrilova N, Quan J, Ye T . L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes. Cell Cycle. 2006; 5(15):1719-29. DOI: 10.4161/cc.5.15.3150. View

Klevernic I, Stafford M, Morrice N, Peggie M, Morton S, Cohen P . Characterization of the reversible phosphorylation and activation of ERK8. Biochem J. 2005; 394(Pt 1):365-73. PMC: 1386035. DOI: 10.1042/BJ20051288. View

Gary R, Ludwig D, Cornelius H, MacInnes M, Park M . The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA-binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21. J Biol Chem. 1997; 272(39):24522-9. DOI: 10.1074/jbc.272.39.24522. View

10.

Halazonetis T, Gorgoulis V, Bartek J . An oncogene-induced DNA damage model for cancer development. Science. 2008; 319(5868):1352-5. DOI: 10.1126/science.1140735. View

11.

Hoeijmakers J . Genome maintenance mechanisms for preventing cancer. Nature. 2001; 411(6835):366-74. DOI: 10.1038/35077232. View

12.

Andersen P, Xu F, Xiao W . Eukaryotic DNA damage tolerance and translesion synthesis through covalent modifications of PCNA. Cell Res. 2007; 18(1):162-73. DOI: 10.1038/cr.2007.114. View

13.

Malliri A, van Es S, Huveneers S, Collard J . The Rac exchange factor Tiam1 is required for the establishment and maintenance of cadherin-based adhesions. J Biol Chem. 2004; 279(29):30092-8. DOI: 10.1074/jbc.M401192200. View

14.

Zhang J, Zhou B, Zheng C, Zhang Z . A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates. J Biol Chem. 2003; 278(32):29901-12. DOI: 10.1074/jbc.M303909200. View

15.

McCaffrey L, Macara I . The Par3/aPKC interaction is essential for end bud remodeling and progenitor differentiation during mammary gland morphogenesis. Genes Dev. 2009; 23(12):1450-60. PMC: 2701573. DOI: 10.1101/gad.1795909. View

16.

St Onge R, Udell C, Casselman R, Davey S . The human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRAD1 and hHUS1. Mol Biol Cell. 1999; 10(6):1985-95. PMC: 25401. DOI: 10.1091/mbc.10.6.1985. View

17.

Gomes X, Burgers P . Two modes of FEN1 binding to PCNA regulated by DNA. EMBO J. 2000; 19(14):3811-21. PMC: 313985. DOI: 10.1093/emboj/19.14.3811. View

18.

Jaskulski D, DeRiel J, Mercer W, Calabretta B, Baserga R . Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science. 1988; 240(4858):1544-6. DOI: 10.1126/science.2897717. View

19.

Gilljam K, Feyzi E, Aas P, Sousa M, Muller R, Vagbo C . Identification of a novel, widespread, and functionally important PCNA-binding motif. J Cell Biol. 2009; 186(5):645-54. PMC: 2742182. DOI: 10.1083/jcb.200903138. View

20.

Her J, Lakhani S, Zu K, Vila J, Dent P, Sturgill T . Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem J. 1993; 296 ( Pt 1):25-31. PMC: 1137650. DOI: 10.1042/bj2960025. View